Evidence map›Paper›PMID 30093943›Full record

ArticleAmerican journal of translational research2018

The molecular mechanism and clinical significance of LDHA in HER2-mediated progression of gastric cancer.

Weiyou Zhu, Ling Ma, Jing Qian, Jin Xu, Tongpeng Xu, Lijun Pang, Hong Zhou, Yongqian Shu, Jianwei Zhou

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The multiple roles of LDH in cancer.Nature reviews. Clinical oncology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Weiyou ZhuDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, People's Republic of China.
Ling MaDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, People's Republic of China.
Jing QianDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, People's Republic of China.
Jin XuDepartment of Molecular Cell Biology and Toxicology, Cancer Center, School of Public Health, Nanjing Medical University 101 Longmian Avenue, Nanjing 211166, Jiangsu Province, People's Republic of China.
Tongpeng XuDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, People's Republic of China.
Lijun PangCancer Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University Suzhou 215228, People's Republic of China.
Hong ZhouCancer Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University Suzhou 215228, People's Republic of China.
Yongqian ShuDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, People's Republic of China.
Jianwei ZhouDepartment of Molecular Cell Biology and Toxicology, Cancer Center, School of Public Health, Nanjing Medical University 101 Longmian Avenue, Nanjing 211166, Jiangsu Province, People's Republic of China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe use of human epidermal growth factor receptor-2 (HER2) as a biomarker for gastric cancer (GC) has greatly helped some patients receive benefit from HER2-targeted therapy. However, the correlation between HER2 and other biochemical markers is unclear. The aim of this study was to examine the relationship between HER2 and lactate dehydrogenase A (LDHA) in GC tissues and GC cells.

methodsThe correlation between clinicopathological features and HER2 was analyzed in 179 cases of GC. The expression of HER2 and LDHA was examined by immunohistochemical staining in 12 pairs of GC tissues and by western blotting in seven pairs of fresh GC tissues and adjacent normal tissues. Wound healing, transwell migration assay, quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR), and LDH activity assays were performed with GC cells.

resultsHER2 expression and serum LDH levels were closely correlated (

conclusionsThe HER2-HIF-1α-LDHA axis may serve as the basis for new methods and strategies for the treatment of GC.

Indexed as

Gastric cancerHER2HIF-1αLDHAmigration

Identifiers

PMID30093943
PMCPMC6079134
OpenAlexW2990629228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.